Christopher Hite, EVP & Chairman, Partnering at Royalty Pharma, holds 393.60K shares in Royalty Pharma (Ticker: RPRX), holds ― shares in Vera Therapeutics (Ticker: VERA), holds ― shares in Kailera Therapeutics, Inc. (Ticker: KLRA).
What is the percentage of profitable transactions made by Christopher Hite?
The percentage of profitable transactions made by Christopher Hite is ―.
What is the average return per transaction made by Christopher Hite?
The average return per transaction made by Christopher Hite is ―.
What stocks does Christopher Hite hold?
Christopher Hite holds: RPRX, VERA, KLRA, XLRN stocks.
What was Christopher Hite’s latest transaction?
Christopher Hite latest transaction was an Uninformative Sell of ―.
What was Christopher Hite's most profitable transaction?
Christopher Hite’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Christopher Hite's role in Royalty Pharma?
Christopher Hite's role in Royalty Pharma is EVP & Chairman, Partnering.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.